Follow
Kleopas A Kleopa
Title
Cited by
Cited by
Year
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and …
SR Irani, S Alexander, P Waters, KA Kleopa, P Pettingill, L Zuliani, ...
Brain 133 (9), 2734-2748, 2010
14682010
Morvan syndrome: clinical and serological observations in 29 cases
SR Irani, P Pettingill, KA Kleopa, N Schiza, P Waters, C Mazia, L Zuliani, ...
Annals of neurology 72 (2), 241-255, 2012
5362012
KCNQ2 is a nodal K+ channel
JJ Devaux, KA Kleopa, EC Cooper, SS Scherer
Journal of Neuroscience 24 (5), 1236-1244, 2004
4892004
Bipap improves survival and rate of pulmonary function decline in patients with ALS
KA Kleopa, M Sherman, B Neal, GJ Romano, T Heiman-Patterson
Journal of the neurological sciences 164 (1), 82-88, 1999
4621999
A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis
P Zisimopoulou, P Evangelakou, J Tzartos, K Lazaridis, V Zouvelou, ...
Journal of autoimmunity 52, 139-145, 2014
3002014
Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems
BM Altevogt, KA Kleopa, FR Postma, SS Scherer, DL Paul
Journal of Neuroscience 22 (15), 6458-6470, 2002
2822002
Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes
L Bataller, KA Kleopa, GF Wu, JE Rossi, MR Rosenfeld, J Dalmau
Journal of Neurology, Neurosurgery & Psychiatry 78 (4), 381-385, 2007
2802007
Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C
VA Street, CL Bennett, JD Goldy, AJ Shirk, KA Kleopa, BL Tempel, ...
Neurology 60 (1), 22-26, 2003
2522003
Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations
KA Kleopa, LB Elman, B Lang, A Vincent, SS Scherer
Brain 129 (6), 1570-1584, 2006
1672006
Autoimmune channelopathies and related neurological disorders
A Vincent, B Lang, KA Kleopa
Neuron 52 (1), 123-138, 2006
1452006
Molecular genetics of X-linked Charcot-Marie-Tooth disease
KA Kleopa, SS Scherer
Neuromolecular medicine 8, 107-122, 2006
1452006
Diverse trafficking abnormalities of connexin32 mutants causing CMTX
SW Yum, KA Kleopa, S Shumas, SS Scherer
Neurobiology of disease 11 (1), 43-52, 2002
1432002
Unique distributions of the gap junction proteins connexin29, connexin32, and connexin47 in oligodendrocytes
KA Kleopa, JL Orthmann, A Enriquez, DL Paul, SS Scherer
Glia 47 (4), 346-357, 2004
1412004
Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects
I Sargiannidou, N Vavlitou, S Aristodemou, A Hadjisavvas, K Kyriacou, ...
Journal of Neuroscience 29 (15), 4736-4749, 2009
1342009
Cellular mechanisms of connexin32 mutations associated with CNS manifestations
KA Kleopa, SW Yum, SS Scherer
Journal of neuroscience research 68 (5), 522-534, 2002
1252002
How do mutations in GJB1 cause X-linked Charcot–Marie–Tooth disease?
KA Kleopa, CK Abrams, SS Scherer
Brain research 1487, 198-205, 2012
1202012
Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy
KA Kleopa, A Drousiotou, E Mavrikiou, A Ormiston, T Kyriakides
Human molecular genetics 15 (10), 1623-1628, 2006
1092006
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter
K Markoullis, I Sargiannidou, N Schiza, A Hadjisavvas, F Roncaroli, ...
Acta neuropathologica 123, 873-886, 2012
882012
X‐linked Charcot‐Marie‐tooth disease
SS Scherer, KA Kleopa
Journal of the Peripheral Nervous System 17 (s3), 9-13, 2012
852012
MuSK autoantibodies in myasthenia gravis detected by cell based assay—a multinational study
AI Tsonis, P Zisimopoulou, K Lazaridis, J Tzartos, E Matsigkou, ...
Journal of neuroimmunology 284, 10-17, 2015
822015
The system can't perform the operation now. Try again later.
Articles 1–20